Obseva

OBSV NASDAQ
10.41
+0.36
+3.57%
交易中 10:07 07/22 EDT
开盘
10.01
昨收
10.05
最高
10.41
最低
10.01
成交量
2,729
成交均量(3M)
4.04万
52周最高
19.40
52周最低
9.20
换手率
0.01%
市值
3.86亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Obseva OBSV股票价格,Obseva股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Obseva SA is a Switzerland-based company active in the pharmaceutical and medical research sector. The Company develops oral compounds to treat women’s reproductive health conditions from conception to birth. Its pipeline includes three product candidates: Linzagolix (OBE2109), an oral gonadotropin-releasing hormone (GnRH) receptor antagonist intended for the treatment of endometriosis (phase 2b of clinical trials) and uterine fibroids (phase 3 of clinical trials); Nolasiban (OBE001), an oral oxytocin receptor antagonist undergoing phase 3 of clinical trials, with the potential to inhibit uterine contractions at the time of embryo transfer, thereby enhancing embryo implantation during assisted reproductive technologies (ART), and OBE022, an oral and selective prostaglandin F2 alpha (PGF2a) receptor antagonist designed to control preterm labor (phase 2a of clinical trials).
展开 >

最近浏览

名称
价格
涨跌幅